Hodgkin lymphoma treatment with ABVD in the US and the EU: neutropenia occurrence and impaired chemotherapy delivery
<p>Abstract</p> <p>Background</p> <p>In newly diagnosed patients with Hodgkin lymphoma (HL) the effect of doxorubicin, bleomycin, vinblastine and dacarbazine (ABVD)-related neutropenia on chemotherapy delivery is poorly documented. The aim of this analysis was to assess...
Main Authors: | Schwenkglenks Matthias, Pettengell Ruth, Szucs Thomas D, Culakova Eva, Lyman Gary H |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-08-01
|
Series: | Journal of Hematology & Oncology |
Online Access: | http://www.jhoonline.org/content/3/1/27 |
Similar Items
-
Neutropenia and Neutropenic Complications in ABVD Chemotherapy for Hodgkin Lymphoma
by: Bhanu Vakkalanka, et al.
Published: (2011-01-01) -
Bladder Carcinoma after ABVD Chemotherapy for Hodgkin’s Lymphoma: A Case Report
by: Aparna Gangopadhyay, et al.
Published: (2012-03-01) -
Tissue is the issue-sarcoidosis following ABVD chemotherapy for Hodgkin's lymphoma: a case report
by: Subbiah Vivek, et al.
Published: (2007-11-01) -
The Use of Filgrastim in Patients with Hodgkin Lymphoma Receiving ABVD
by: Adam F. Binder, et al.
Published: (2017-10-01) -
Maternal ABVD chemotherapy for Hodgkin lymphoma in a dichorionic diamniotic pregnancy: a case report
by: Camille Cotteret, et al.
Published: (2020-04-01)